Invista To Construct ADN Plant In China

Wichita, Kan.-based Invista has announced it will invest more than $1 billion in a 300,000-ton adiponitrile (ADN) facility in China to meet the local demand for the nylon 6,6 intermediate chemical. Construction will begin in 2020 and production is expected to come online in 2023.

“We are pleased by the feedback we have received in the market and are confident we will reach agreements with selected partners over the next few months; so our shareholders have agreed to proceed with the project,” said Bill Greenfield, president, Invista Intermediates. “Combined with the significant investments being made in our existing ADN plants, this decision further demonstrates Invista’s commitment to the global industry.”

“Invista supplies more of the merchant market than any other ADN producer, so we want to ensure those customers have the best technology available,” said Kyle Redinger, vice president of Invista Intermediates, Asia Pacific, and 2017 Magnolia Silver Award Winner. “The last world-scale plant was constructed more than 35 years ago, so this is a special time for the industry, and I am extremely proud to lead Invista’s efforts to deliver this new facility.”

September/October 2018

SHARE